{
    "Title": "Human Trypanosoma cruzi chronic infection leads to individual level steady-state parasitemia: Implications for drug-trial optimization in Chagas disease",
    "URL": "https://doi.org/10.1371/journal.pntd.0010828",
    "Published": "November 21, 2022",
    "Subject_Areas": [
        "Parasitemia",
        "Parasitic diseases",
        "Chagas disease",
        "Polymerase chain reaction",
        "Parasitology",
        "Bloodstream infections",
        "Hidden Markov models",
        "Blood"
    ],
    "Authors": {
        "Pablo M. De Salazar": [
            "Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America"
        ],
        "Sergio Sosa-Estani": [
            "Drugs for Neglected Diseases Initiative. Rio de Janeiro, Brazil",
            "Epidemiology and Public Health Research Centre, CONICET, Buenos Aires, Argentina"
        ],
        "Fernando Salvador": [
            "Department of Infectious Diseases, Vall d’Hebron University Hospital, International Health Program of the Catalan Institute of Health (PROSICS), Barcelona, Spain",
            "Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain"
        ],
        "Elena Sulleiro": [
            "Department of Microbiology, Vall d’Hebron University Hospital, International Health Program of the Catalan Institute of Health (PROSICS), Barcelona, Spain",
            "Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain"
        ],
        "Adrián Sánchez-Montalvá": [
            "Department of Infectious Diseases, Vall d’Hebron University Hospital, International Health Program of the Catalan Institute of Health (PROSICS), Barcelona, Spain",
            "Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain"
        ],
        "Isabela Ribeiro": [
            "Drugs for Neglected Diseases Initiative, Geneve, Switzerland"
        ],
        "Israel Molina": [
            "Department of Infectious Diseases, Vall d’Hebron University Hospital, International Health Program of the Catalan Institute of Health (PROSICS), Barcelona, Spain",
            "Instituto René Rachou-FIOCRUZ Minas, Laboratório de Triatomíneos e Epidemiologia da Doença de Chagas, Belo Horizonte, Brazil",
            "Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain"
        ],
        "Caroline O. Buckee": [
            "Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America"
        ]
    }
}